SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    P. Ferenci, G. Dusheiko, Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis, Gut, 2014, 63, 7, 1033

    CrossRef

  2. 2
    Peter Ferenci, Rodrigo Aires, Kimberly L. Beavers, Manuela Curescu, Paulo R. Abrão Ferreira, Michael Gschwantler, Stefan Ion, Dominique Larrey, Mojca Maticic, Massimo Puoti, János Schuller, Istvan Tornai, Anna Tusnádi, Diethelm Messinger, Fernando Tatsch, Andrzej Horban, Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients, Hepatology International, 2014, 8, 1, 83

    CrossRef

  3. 3
    A. Maieron, P. Salzl, M. Peck-Radosavljevic, M. Trauner, S. Hametner, R. Schöfl, P. Ferenci, M. Ferlitsch, Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C , Alimentary Pharmacology & Therapeutics, 2014, 39, 3
  4. 4
    Patrick Marcellin, Curtis Cooper, Luis Balart, Dominique Larrey, Terry Box, Eric Yoshida, Eric Lawitz, Peter Buggisch, Peter Ferenci, Martin Weltman, Emily Labriola–Tompkins, Sophie Le Pogam, Isabel Nájera, Denise Thomas, Gregory Hooper, Nancy S. Shulman, Ying Zhang, Mercidita T. Navarro, Chin Yin Lim, Michael Brunda, Norah A. Terrault, Ellen S. Yetzer, Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection, Gastroenterology, 2013, 145, 4, 790

    CrossRef

  5. 5
    S. Beinhardt, K. Rutter, A. F. Stattermayer, P. Ferenci, Revisiting the Predictors of a Sustained Virologic Response in the Era of Direct-Acting Antiviral Therapy for Hepatitis C Virus, Clinical Infectious Diseases, 2013, 56, 1, 118

    CrossRef

  6. 6
    Patrick Marcellin, Hugo Cheinquer, Manuela Curescu, Geoffrey M. Dusheiko, Peter Ferenci, Andrzej Horban, Donald Jensen, Gabriella Lengyel, Alessandra Mangia, Denis Ouzan, Massimo Puoti, Maribel Rodriguez-Torres, Mitchell L. Shiffman, Manuela Schmitz, Fernando Tatsch, Mario Rizzetto, High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials, Hepatology, 2012, 56, 6
  7. 7
    Peter Ferenci, Response guided therapy in patients with chronic hepatitis C – Yesterday, today and tomorrow, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 463

    CrossRef